Concepedia

Andrew J. Nicol

AJ

42

Publications

3.2K

Citations

29

H-Index

1973

Active since

Affiliations

The University of Queensland(Current)

QIMR Berghofer Medical Research Institute

Japanese Red Cross Society, Japan

Greenslopes Private Hospital

Yokohama City University

Andrew J. Nicol is an author at The University of Queensland specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1973–2020

42

Publications

42

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

Mie Nieda, Miki Okai, Andrea Tazbirkova et al. · Blood · 2003 · 358 citations

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold et al. · The Lancet Haematology · 2019 · 249 citations · Full text

, , +6

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Saad Z. Usmani, Fredrik Schjesvold, Albert Oriol et al. · The Lancet Haematology · 2019 · 237 citations · Full text

, , +7

Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours

Andrew J. Nicol, Hirotake Tokuyama, Stephen R. Mattarollo et al. · British Journal of Cancer · 2011 · 236 citations · Full text

Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma

Yu Abe, Masato Muto, Mie Nieda et al. · Experimental Hematology · 2009 · 168 citations

Rows per page

1–5 of 42